Aiming for zero medicine harm

It has been 3 years since medicine safety was announced as Australia’s 10th National Health Priority Area. How are we going at reducing harm...

Research winners for PSA18

Researchers examining polypharmacy within aged populations have won the best paper and best poster categories at PSA18. Lauren Corre and a team of University of...

SSRIs for mild cognitive impairment to Alzheimer’s disease

Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment? An estimated 10% of people...

The mental health researcher

Claire O’Reilly was an intern pharmacist when a patient experience got her thinking about a pharmacist’s role in improving mental health care. Now she’s...

Rural rewards

From a stint in the Top End to owning a pharmacy in remote NSW, Anēwan and Wiradjuri woman Kellie Beckenham MPS is passionate about...

Managing gastrointestinal problems in infants

        Opting for a better approach. Proton pump inhibitors (PPIs) were developed in the 1980s. Omeprazole, the first to be marketed, is on the WHO Model...